Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot

Not Applicable

• Conditions: AIDS; Hepatitis B; Hepatitis C
• Interventions: Diagnostic Test: Blood collection using Dried Blood Spot

• Registration Number: NCT05390424
• Lead Sponsor: University Hospital, Rouen

Brief Summary

The aim of the study is to screen for hepatitis B, hepatitis C and AIDS viruses using a Dried Blood Spot in drug users

Detailed Description

Not available

Study Timeline

• Status Verified: 2022-05
• Study First Submitted: 2022-05-20
• Study First Submitted QC: 2022-05-20
• Last Update Submitted: 2022-05-20
• Study First Posted: 2022-05-25
• Last Update Posted: 2022-05-25
• Study Start: 2022-06
• Primary Completion: 2023-09
• Study Completion: 2023-09

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

• Former or active intravenous and/or nasal drug user
• Person on opiate substitution therapy

Exclusion Criteria

• Person with known active viral infection(s)

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Drug user	Blood collection using Dried Blood Spot	Drug users will be screened for Hepatitis C, Hepatitis B and AIDS using Dried Blood Spot for blood collection

Primary Outcome Measures

Name	Time	Method
Number of person with an active hepatitis B infection	Day 1
Number of person with an active AIDS infection	Day 1
Number of person with an active hepatitis C infection	Day 1

Trial Locations

Locations (1)

CSAPA la Boussole; 🇫🇷 Rouen, France